CULTIVATE TECHNOLOGY INC. – Trademark Portfolio
Entity Type: 03
CULTIVATE TECHNOLOGY INC. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include CULTIVATE. The owner is based in SAN FRANCISCO, CA.
2 EMBARCADERO CENTER
8TH FLOOR
SAN FRANCISCO, CA 94111
Showing of trademarks Trademarks
Trademark Classifications
CULTIVATE TECHNOLOGY INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does CULTIVATE TECHNOLOGY INC. have?
CULTIVATE TECHNOLOGY INC. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.
What trademark classes does CULTIVATE TECHNOLOGY INC. file in?
CULTIVATE TECHNOLOGY INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment). Class 35 covers advertising; business management; business administration; office functions.
What are CULTIVATE TECHNOLOGY INC.'s most well-known trademarks?
CULTIVATE TECHNOLOGY INC.'s registered trademark portfolio includes well-known marks such as CULTIVATE. These are among 1 currently registered trademark in the portfolio.
What is CULTIVATE TECHNOLOGY INC.'s trademark registration success rate?
CULTIVATE TECHNOLOGY INC. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.